Addition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group.

Beksaç, Mehmet SinanHaznedar, RaufFıratlı, Tülin TuğlularÖzdoğu, HakanAydoğdu, İsmetKonuk, NahideSucak, Gulşan AyhanKaygusuz, IşıkKarakuş, SavaşKaya, EminGülbaş, ZaferÖzet, GülsümGöker, HakanÜndar, Levent2022-06-092022-06-092009-11-20Beksaç, M. vd. (2009). "Addition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group". Blood, 114(22), 746-747.0006-4971http://hdl.handle.net/11452/26995Bu çalışma, 05-08 Aralık 2009 tarihleri arasında New Orleans[Luisana]’da düzenlenen düzenlenen 51. Annual Meeting of the American-Society-of-Hematology’da bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessHematologyAddition of thalidomide (t) to oral melphalan/prednisone (mp) in patients with multiple myeloma: Initial results of a randomized trial from the Turkish myeloma study group.Meeting Abstract00027272580224874674711422Hematology